ONCO · NASDAQ
Onconetix (ONCO) Stock Price & Fundamentals
Onconetix (ONCO) closed at $313.21 on Oct 9, 2026, down 1.73% from the previous close of $318.71.
Share price, past year
1Y +5.15%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $313.21 |
| Sep 30, 2026 | $326.15 |
| Aug 31, 2026 | $320.86 |
| Jul 31, 2026 | $316.84 |
| Jun 30, 2026 | $313.33 |
| May 29, 2026 | $302.25 |
| Apr 30, 2026 | $317.53 |
| Mar 31, 2026 | $316.95 |
| Feb 27, 2026 | $333.13 |
| Jan 30, 2026 | $317.09 |
| Dec 31, 2025 | $301.87 |
| Nov 28, 2025 | $303.14 |
| Oct 31, 2025 | $313.05 |
Key statistics
- Market cap
- $1.19B
- P/E (TTM)
- 0.7
- EPS (TTM)
- $440.61
- Revenue (TTM)
- $645.82K
- Net income (TTM)
- −$10.20M
- Shares outstanding
- 3.8M
- Dividend yield
- —
- 52-week range
- $293.98 – $338.40
Onconetix's market cap is $1.19B, based on a share price of $313.21 and 3.8M shares outstanding as of Jun 30, 2026.
Financials
Onconetix reported revenue of $815.37K for fiscal 2025, down 67.70% from fiscal 2024.
Onconetix reported a net loss of $14.03M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $815.37K | −67.7% | −$14.03M | −1,721.0% | −$16.56 | — |
| FY2024ended Dec 31, 2024 | $2.52M | +4,217.3% | −$58.69M | −2,325.2% | −$1,823.39 | −$10.52M |
| FY2023ended Dec 31, 2023 | $58.47K | — | −$37.41M | −63,986.5% | −$87.45 | −$13.58M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $17.12K | −$2.87M | −$1.28 |
| Q1 FY2026ended Mar 31, 2026 | $21.46K | −$4.21M | −$6.71 |
| Q4 FY2025ended Dec 31, 2025 | $303.60K | $5.67M | $454.85 |
| Q3 FY2025ended Sep 30, 2025 | $303.65K | −$8.78M | −$6.25 |
| Q2 FY2025ended Jun 30, 2025 | $106.49K | −$2.37M | −$237.91 |
| Q1 FY2025ended Mar 31, 2025 | $101.63K | −$8.55M | −$227.25 |
| Q4 FY2024ended Dec 31, 2024 | $711.98K | −$29.44M | $637.36 |
| Q3 FY2024ended Sep 30, 2024 | $406.86K | −$3.83M | −$249.08 |
Company profile
- Name
- Onconetix, Inc.
- Ticker
- ONCO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 201 E. Fifth Street, Suite 1900, Cincinnati, OH 45202
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001782107
Recent SEC filings
- Sep 14, 2026
- Aug 13, 2026
- Jul 29, 2026
- May 19, 2026
- May 14, 2026
- May 13, 2026
- May 4, 2026
- Apr 24, 2026
Frequently asked questions
What is Onconetix's stock price?
Onconetix (ONCO) closed at $313.21 on Oct 9, 2026, down 1.73% from the previous close of $318.71.
What is Onconetix's market cap?
Onconetix's market cap is $1.19B, based on a share price of $313.21 and 3.8M shares outstanding as of Jun 30, 2026.
How much revenue does Onconetix make?
Onconetix reported revenue of $815.37K for fiscal 2025, down 67.70% from fiscal 2024.
What is ONCO's P/E ratio?
Onconetix's price-to-earnings ratio is 0.7, based on trailing twelve-month diluted EPS of $440.61.
Does Onconetix pay a dividend?
Onconetix's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Onconetix, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures